5-Amino-1MQ Tablets

Each order of AndroNorth 5-Amino-1MQ Tablets contains one (1) satchet of sixty (60) tablets, each containing 50mg of highly pure 5-Amino-1MQ.

5-Amino-1MQ is a synthetic small-molecule compound classified as a nicotinamide N-methyltransferase (NNMT) inhibitor, primarily studied for its potential role in regulating cellular metabolism, energy balance, and metabolic health. It functions by selectively inhibiting NNMT activity, an enzyme involved in nicotinamide metabolism and methylation pathways.

By suppressing NNMT activity, 5-Amino-1MQ helps increase intracellular levels of nicotinamide and NAD⁺ precursors, which play critical roles in cellular energy production and metabolic regulation. This mechanism supports enhanced mitochondrial function, improved lipid utilization, and more efficient glucose metabolism.

Through its influence on NAD⁺-dependent pathways, 5-Amino-1MQ has been shown in preclinical studies to promote increased energy expenditure and reduced fat accumulation. These effects are associated with improved metabolic flexibility and may contribute to healthier body composition under controlled experimental conditions.

Unlike broad-spectrum metabolic modulators, 5-Amino-1MQ is designed to act selectively on NNMT, allowing for more targeted regulation of methylation and energy-related pathways. This selectivity may reduce unintended disruption of other enzymatic systems when used in research environments.

In addition to its metabolic effects, 5-Amino-1MQ has demonstrated potential benefits related to cellular stress response and mitochondrial efficiency. By supporting NAD⁺ availability, it may help improve cellular resilience and reduce metabolic dysfunction linked to obesity and insulin resistance.

5-Amino-1MQ is primarily utilized in laboratory and experimental research to study NNMT signaling, metabolic regulation, obesity-related pathways, and NAD⁺ metabolism. Ongoing studies continue to investigate its long-term safety profile and potential therapeutic applications in metabolic disease models.

Key Points

Action:
Acts as a selective NNMT inhibitor to enhance NAD⁺-related pathways, increase energy expenditure, and improve metabolic efficiency.

Indications:
Used in research related to obesity, metabolic disorders, insulin resistance, NAD⁺ metabolism, and mitochondrial function.

Difference from Other Metabolic Modulators:
5-Amino-1MQ targets NNMT specifically, offering a more focused approach to regulating methylation and energy pathways compared to broader metabolic agents, with potential for improved selectivity and reduced off-target effects.